Our bioinformatics consulting services support every step of the multiomics journey. Explore how we help teams move faster, smarter, and with complete analytical confidence.
Explore moreExplore how we support Pharma & Biotech companies in solving critical R & D challenges with bioinformatics.
View moreGAIA® demonstrates superior overall performance in taxonomic classification on long-read metagenomic datasets than alternative solutions.
Read WhitepaperHelping a leading European clinical diagnostics laboratory scale microbiome analysis.
View case studyMICK-MAGMATM is a secure, cloud-based solution that utilizes whole genome sequencing data to support Mycobacterium tuberculosis surveillance.
Transform sequencing data into clear, harmonized resistance and transmission insights that streamlines research, assists surveillance of emergent resistance, and provides information to improve drug-resistant TB program planning.
Adaptable to diverse NGS workflows and continuously updated with the latest scientific knowledge, MICK-MAGMATM empowers public health authorities, laboratories, researchers, and field teams to unlock the full potential of genomics to end TB.
Automated drug resistance interpretation for both first- and second-line TB drugs based on the WHO catalog v2 and proprietary algorithms.
Treatment insights, translating genomic outputs into treatment-relevant research insights.
Integration of complementary NGS approaches, such as targeted sequencing (tNGS) and whole genome sequencing (WGS) for maximum flexibility when applied to research and/or surveillance applications.
Coming soon: Genomic visualization tools, transforming WGS data into intuitive representations of genetic relatedness and transmission networks.
MICK MAGMATM is the result of a collaborative effort supported by the following leading research partners.
Get curated resistance and transmission signals ranked by strength of evidence.
Surface high-impact TB clusters, drugs and cases to review before everything else.
The complexity of genomes (human and non-human), which requires exceptional analytical power.
The heterogeneity and variable quality of omics data, along with the lack of standardized protocols.
The need for robust computational tools to process the sheer volume of data from high-throughput technologies.
The difficulty of translating complex data into applicable results tailored to each stakeholder’s unique needs, which demands the highest level of scientific and technical expertise.
This product is For Research Use Only (RUO). Not for use in diagnostic procedures.
Leave us your details and one of our specialists will get in touch with you as soon as possible.
Leave us your inquiry, and we will get back to you shortly.
Leave us your details and one of our specialists will get in touch with you as soon as possible.
Leave us your details and one of our specialists will get in touch with you as soon as possible.